The determination of 2'-5'-oligoadenylate synthetase in peripheral blood mononuclear cells is used äs a biological response parameter during therapy with interferon and in the diagnosis of diseases related to the interferon System. In this communication, some general aspects concerning the preparation of 2'-5'-oligoadenylate synthetase from peripheral blood mononuclear cells and the incubation conditions of the 2'-5'-oligoadenylate synthetase reaction are reported. Four analytical procedures for the determination of the products formed during the 2'-5'-oligoadenylate synthetase reaction were comparatively investigated and the advantages and limitations of the assays are discussed. As an example of possible clinical application, the levels of 2'-5'-oligoadenylate synthetase were determined in the mononuclear cell fraction of peripheral blood from healthy persons äs well äs from children with chronic myelogenous leukaemia.
Introduction
Interferons are (glyco)proteins with pleiotropic effects (antiviral, antipröliferative, immunomodulative). The molecular mechanisms of their action is not yet fully understood, but some of the antiviral and perhaps antiproliferative effects are probably related to the so-called 2'-5'-oligoadenylate System (l, 2); treatment of cells with interferon leads to the de novo synthesis of 2'-5'-Qligpadenylate synthetase ( fig. 1 ). This enzyme is able to produce oligoadenylates from ATP in the presence of double-stranded RNA(dsRNA) according to the equation: ATP => ppp5'A2' (p5'A) n^ + (n-l)PP, (n = 2-14)
The'adenosine residues of these oligoadenylates are liüked by phosphodiester bonds in the unusual 2'-5'-position. 2'-5'-Oligoadenylates greater than the dimeric form (n = 2) activate an endoribonuclease (RNaseL) which cleaves mRNA. A third enzyme, 2'-5'-oligoadenylate phosphodiesterase, destroys 2'-5'-oligoadenylates, so that the RNase returns to its inactive state. Additionally to ^-S'-oligoadenylates, 2'-S'-Qligpadenylate-cores (^-S'-oligoadenylates without the triphosphate residues on the terminal S'-position) are also found in cells. They do not activate the endoribonuclease, but they are also biologically active (3) . The cellular levels of the 2'-5 / -oligoadenylate synthetase are subject to change under certain conditions, e. g. during differentiation (4) . It shows an especially marked elevation after interferon treatment. Therefore, the determination of 2'-5'-oligoadenylate synthetase has been widely used in the diagnosis of different diseases connected with the interferon System (5 -12) and äs a response parameter during interferon therapy (13, 14) . Several methods for the determination of 2'-5'-oligpadenylate synthetase in different cell types have been described (for review see 1. c. (1)). All these assays consist of three Steps: preparation of 2'-5'-oligoadenylate synthetase from cells, incubation of the enzyme with ATP and analysis of the reaction products. However, because several different analytical procedures are used and incubation conditions are not uniform, greatly differing results have been reported (factor 10). The aim of our study was to standardize the preparation and incubation conditions for the determination of ^-S'-oligoadenylate synthetase in peripheral blood mononuclear cells, and to compare the test System according to Schattner (which is wideiy used in many laboratories) with some other assays in order to find out which of them is most suitable for application in the clinical laboratory. 2'-5'-Oligoadenylate synthetase levels were estimated in peripheral blood mononuclear cells from healthy persons. As an example of a clinical application, they were also estimated in children with chronic myelogenous leukaemia. 
Materials and Methods

Materials
Methods
In figure 2 , a schematic survey of the test Systems described subsequently is given.
Preparation of cell lysates
Peripheral blood mononuclear cells were isolated üsing lymphoprep (Nyegaard, Oslo). The isolated cells were suspended in MEM (minimal essential medium coiitaining 5% foetal calf serum). The ceil Suspension (l 10 6 cells per ml) was incubated at*37°C ovefnight without or with 1QOO U/ml interferon-a. After centrifugation, the supernatant was removed completely and the cell pellets were treated with lysis buffer (100 μΐ per 2 χ 10 6 cells, 10 minutes at 4 °C). After centrifugation (l 5 000 g, 8 minutes), the 2'-5'-oligoadenylate synthetase-containing supernatant was collected and frozen at -70 °C.
Binding of 2'-5'-oligoadenylate synthetase on poly(rI):(rC)^ag rose beads and perfprmance of the 2'-5'-oligoadenylate synthetase reaction Poly(rI):(rC)ragarPse beads were washed with 20 mmol/1 sodium phosphate buffer containing 200,mmol/l sodmm Chloride, pH 7.5 (this step, however, can be avoided). The beads were suspended in buffer A (l + l by vol.) and 40 ul aUquots were transferred into Eppendorf cups. After brief centrifugation and removal of the superaatant, 20 ul cell extracts were added (25 minutes incubation at room temperatufe). Following this bindî ng reaction, the agarose-beads were washed twice with 750 ul buffer A. The ^'-S'-p goadenylate synthetase reaction was .started by addition of incubation buffer (20 μΐ) , and the incubation was carried put for 2^20 hours at 30 °C. The reaction was stopped by heating the samples (2 minutes at 95 °C).
Until this step, the test procedure is the same for all fpur methods described.
Analysis of the 2 / -5'-oligoadenylates formed during the 2'-5 / -oligoadenylate synthetase reaction All assays were carried out according to the original test protocols, with small modifications.
Schattner assay (16) (Standard and reference test System)
After the 2'-5'-oligoadenylate synthetase reaction, 20 μΐ bacterial alkaline phosphatase (100 U/ml Trizma (140 mmol/1; Sigma, M nchen) were added to the reaction vessels (l hour incubation time at 37 °C). This step is carried out in the same way s in the assays of Lodemann & Ball (see below and fig. 2 ).
After incubation with bacterial alkaline phosphatase, the P 2 P]-labelled 2'-5'-oligoadenylate cores were separated from P 2 P] on small columns, which were prepared in l ml Eppendorf Standard tips using 600 ul alumina Suspension (alumina, type WA-4: acid; Sigma, M nchen, suspended in water, l -f l by vol.). The columns were washed with 3 ml glycine-HCl (l mol/1, pH 2). Samples (20 μΐ) were applied to the columns, and the 2'-5'-oligoadenylate cores were eluted with 3ml giycine-HCl and their radioactivity determined
Principles ofevaluation of the Schattner assay
Because of the short half-life time of The mean value from 5 healthy donors (normal collective) was arbitrarily set at 1.0. 2'-5'-oligoadenylate synthetase activity present in the cell lysate from one of these 5 donors was adjusted to this mean value by sample dilution. Aliquots of this sample were frozen at -70 °C and were subsequently used s an internal reference sample for all further investigations using the same Charge of [
• \ Additionally, the 2'-5'-oligoadenyIate synthetase activity was estimated in peripheral blood mononuclear cells after in vitro treatment with interferon (l 8 hours).
The ratio:
activity after interferon treatment activity without interferon treatment is expressed s the elevation factor.
Lodemann assay (14)
After treatment with bacterial alkaline phosphatase (see above), samples were diluted with l ml Tris-HCl (0.5 mmol/1), pH 7.6. Following centrifugation, l ml of the supernatant was applied to DEAE-52 cellulose columns (Whatman DE 52), prepared in l ml plastic syringes (packing volume: 600 μΐ). The columns were equilibrated with Tris-HCl, pH 7.6.
After addition of 15 ml 0.5 mmol/1 Tris-HCl, pH 7.6 (elution of pHJadenosine), the 2 / -5 / -oh'goadenylate cores were eluted with 3 ml buffer (0.5 mmol/1 Tris-HCl, 0.2 mol/1 NaCl, pH 7.6). l ml aliquots were mixed with 10 ml scintillation cocktail (Unisolve 100, Zinsser, Frankfurt), and counted.
Ball& White assay (17)
After treatment with bacterial alkaline phosphatase, 10 μΐ samples were spotted onto l cm 2 DEAE-cellulose paper (Whatman, DE 81), washed 8 times with distilled water and transferred into scintillation vials. [ 3 H]-labeled 2'-5'-oligoadenylate cores, bound on the filters, were eluted with 300 mmol/1 KC1. The radioactivity was measured after addition of 10 ml Unisolve.
Radiobinding assay (15) For test performance, the following were added to Eppendorf tubes: a) 20 μΐ rabbit reticulocyte lysate (contains RNaseL) b) 10 μΐ 2-5A [ The tubes were incubated at 4 °C for 90 minutes. Subsequenlty, the incubation mixture was transferred to nitrocellulose filters, removed by suction, and the filters washed three times with 1ml of buffer 2. Radioactivity on the filter discs (2-5A [ 32 P]pCp bound on RNaseL) was counted after addition of 10 ml Unisolve 100.
Results
Isolation of 2'-5'^oligoadenylate synthetase from lysates of peripheral blood mononuclear cells using poly(r!):(rC)-agarose bead$ Experiments were performed to determine the amount of poly(r!):(rC)-agarose Suspension required to bind the 2'-5'-oligoadenylate synthetase present in cell lysates. As depicted in figure 3 5 30 μΐ were s fficient to bind the enzyme in cell lysates from 4 χ l O 5 peripheral blood mononuclear cells pretreated with 1000 IU interferon-α per ml.
Furthermore, we investigated whether enzymes that attack either ATP or 2'-5'-oligoadenylates can influence the 2'-5'-oligo denylate synthetase reaction if they are isolated s impurities on the poly(rI):(rC)-agarose. As a model System for ATP-cons ming enzymes, hexokinase (in the presence of l mmol/1 glucose) was added to the 2'-5'-oligoadenylate syiithetase reaction mixture. Table l a shows that ADP formed by the hexokinase reaction was reconverted coiiipletely to ATP in the presence of creatine phosphate and creatine kinase. These reagents are therefore added to the incubation buffer s an ATP-regenerating system. In order to clarify whether any bound 2'-5'-oligoadenylate phosphodiesterase activity could influence the 2'-5'-oligoadenylate synthetase reaction, lysates of peripheral mononuclear blood cells and snake venom phosphodiesterase, known to be able to split 2'-5'-oligoadenylates (18) , were added to the incubation mixture after stopping the 2'-5'-oligoadenylate synthetase reaction. Tabje Ib shows that degradation occurs only in the presence of snake venom phospho^· diesterase (positive control), but not in the presence of cell lysate.
Time and concentration dependence of the 2'-5'-oligoadenylate synthetase reaction
Under Standard incubation conditions, the 2'-5'-oligoadenylate synthetase reaction follows a linear course for at least 20 hours, if the enzyme is bound to poly(rI):(rC)-agarose beads ( fig. 4 a) . Figure 4b shows that there is also a linear correlation between the turnover rate and the amount of cell lysate (i. e. the amount of 2'-5'-oligoadenylate synthetase). In two other series of experiments carried out in the same way, using cell lysates of 5 other healthy persons and other charges of [a- Finally, peripheral blood mononuclear cells from one person were collected six times during a time period of two months. The coefficient of Variation of the 2'-S'-oligoadenylate synthetase levels in these cell lysates was 24.2%. In this case, the 2 / -5 / -oligoadenylate synthetase activity of all six samples was estimated on the same day.
Comparison of the 2'-5'-oligoadenylate synthetase assay according to Schattner with other assays
Comparison between the Schattner assay (16) and the assays of Lodemann (14) and Ball (17) The common feature of these three assays is that 2'-5'-oligoadenylates formed during the 2'-5'-oligoadenylate synthetase reaction are converted into the corresponding 2 / -5 / -oligoadenylate cores by treatment with bacterial alkaline phosphatase (fig. 2) ; this allows an easier Separation of the reaction products. Table 3 shows that the 2'-5'-oligoadenyläte synthetase levels obtained with the Schattner assay are lower than those of the two other assays. This reflects the Situation that in the Schattner assay part of the radioactivity incorporated from [ with interferori- 15 30 6.1 ± 0.76 9.8 ± 0.6 9.4 ± 0.8 14.1 ± 1.27 18.1 ± 0.5 23.0 ± 3.3 Lysates were from 2 1Ö
7 peripheral blood mononuclear cells, pretreated or not with 1000 U/ml interferon-a. Radioactivity incorporated is expressed in % of the radioactivity originally present in ATP.
Comparative estimation of 2'-5'-oligoadenylate synthe* läse with the assay of Schattner & Knight (radiobinding assay (15))
In the radiobinding assay, 2'-5'-oligoadenylates (trimeric and higher multimeric forms) compete with 2-5A [ 1 -0,25, fig.  6 ). However, after in vitro treatment with interferon, the 2'«5 / -oligoadenyläte synthetase levels were strongly elevated (up to 35-fold compared to only 2-4 fold in healthy persons, estimated in this set of experiments). Therefore, the 2'-5'-oligoadenylate synthetase levels fmally obtained after in vitro treatment \vith Interferon were the same magnitüde äs those from healthy donors.
Discussiop
Assays for the determiiiation of ^-S'-oligoadenylate synthetase can be classified äs:
1) biological assays (RNA-cleavage assay (21-23), protein synthesis Inhibition assay (24)) 2) binding assays (radiobinding assay (l 5), radioimmunoassay (25), enzymeimmunoassay (26, 27) ) and 3) assays that determine 2 / -5'-oligoadenylates formed during the 2 / -5'-oligoadenylate synthetase reaction (14, 16, 17, 28, 29) .
We compared four analytical procedures. From the binding assays, we chose the radiobinding assay according to Knight because all the necessary Substrates are commercially available. From the third group, three well established assays were carried out (according to Sehattner, Lodemann and Ball).
The direct determination of ^-S'-oligoadenylate synthetase in cell lysates (solution assay, (19) ) is restricted by several factors, mainly enzymic reactions that either could consume the Substrate of the 2'-5'-oligoadenylate synthetase reaction (ATP) or destroy the products formed (2'-5'-oligoadenylates). Additionally, because of the small turnover rate of the 2'-5'-oligoadenylate synthetase reaction, long incubation times (several hours) are necessary for a clear signalto-noise background. During this prolonged incubation time, the enzyme is inactivated in solution, but not if it is fixed to a solid matrix. Therefore, 2'-5'-oligoadenylate synthetase is usually isolated from cell lysates using Poly(rI):(rC)-agarose beads. This allows its rapid isolation from cell lysates without co-isolation of ATP-or 2'-5'-oligoadenylate degrading enzymes in ämounts that could influence the test procedure (tab. 1).
Summarizing the advantages and disadvantages of all these procedures, the assay according to Schattner (16) proved -in our view -to be most suitable for routine analysis, mainly with regard to its practicality. Forty to fifty samples in duplicate can be analysed simultaneously, the preparation of alumina colums for Separation of 2'-5'-oligoadenylate cores from [ 32 P] can be performed quickly and easily, and the Separation is very effective; blank values are rather low, allowing the determination of 2'-5'-oligoadenylate synthetase even for a small turnover of ATP.
This latter point is of special importance, because it is hardly possible to perform the assay under enzymesaturated conditions: Even ATP concentrations äs high äs 10 mmol/1 (in most assays described ATP concentrations between l and 3 mmol/1 are used) do not produce a constant turnover rate in the MichaelisMenten plot (data not shown). Therefore, measurement at a low ATP turnover, provides less opportunity for variations in the velocity of the enzyme reaction. Based on these theoretical considerations and on our own practical experiences with this test System, inĉ ubation conditions that lead to an ATP turnover between 5 and 15% can be recommended for optimal test performance. This can be achieved, e. g. by using extracts from about 4 l O 5 peripheral blood mononuclear cells and 5-20 hours incubation time.
The following points concerning the reproducibility of the Schattner assay are worth noting. Using a freshly prepared Charge of [ -oligoadenylate synthetase levels are relatively small within the first days, but with increasing Prolongation of storage time, the turnover rates decrease; this is probably due to the increasing decomposition of ATP by radiolysis. Because all turnover rates are related to the same internal Standard, this fact is not a severe problem.
In the experiments described above, an internal Standard was always established for each new set of experiments (i. e. for each new Charge of [ 32 P]ATP). However, because 2'-5'-oligoadenylate synthetase-containing cell lysates can be stored at -70 °C for a long period of time, it should be possible to use the same internal Standard for several sets of experiments. This is especially recommended if the 2'-5'-oligoadenylate synthetase is monitored during long term interferon therapies.
In contrast to its practicability, the Schattner assay hasche following severe theoretical limitatiön. It is not possible to estimate the 2'-5'-oligoadenylate synthetase activity exactly, because more than one class of 2'-5'-oligoadenylates are formed during the 2'-5'-oligoadenylate synthetase reaction; after treatment with bacterial alkaline phosphatase, only 50% of the radioactivity originally incorporated into the dimeric form can be registrated (ppp*Ap*A -> Ap*A + P* + 2P), only two thirds of the triineric form (ppp*Ap*Ap*A -> Ap*Ap*A + P* + 2P) and so on. Although the 2'-5'-oligoadenyi£te synthetase activity using the Schattner assay is often expressed äs ATP turnover rate, this is not valid, because the composition of the 2'-5'-oligoadenylates generated during any 2'-5'-oligoadenylate synthetase reaction is unknown. The correct way to express the turnover rate of the 2'-5'-oligoadenylate synthetase reaction is therefore to estimate the percent radioactivity incorporated from ATP into 2'-5'-oligoadenylate cores. Because all samples are related to internal Standards and are measured in the same way, this evalüation is sufficiently correct.
The problem described does not exist in the two öther assays, which are carried out according to the same test principle, but using [ H]adenosine by DEAE-ion exchange chromatography. The only drawbäck of this assay is that it is not äs easy to handle äs the Schattner assay (column preparation and elution procedüre); this is especially inconvenient when a large number of samples has to be processed. Nevertheless, this test allows the exact determination of the ATP turnover rate and the use of [ The third assay in this group, the assay of Ball & White (17) , is most easily performed, because after treatment with bacterial alkaline phosphatase the 2'-S'-oligoadenylate cores are only spotted on DEAEion-exchange filters; the [ 3 H]adenösine residues are removed from the filters by a simple washing procedüre using H 2 O. Unfortunately, the sensitivity of this test is limited (high background values). Therefpre, small turnover rates cannot be detected and its rep roducibility was-in our hand-worse than that of the two other assays described above.
The fourth assay investigated, the radiobinding assay according to Knight (15) is very sensitive, but there are some disadvantages. A calibration curve must always be established, and it is recommended that the test be performed using several sample dilutions in order to get 2 / -5 / -oligoadenylate concentrations well fitted in the calibration curve ränge. The test is based on the binding of oligoadenylates to RNaseL present in high amounts in reticulocyte lysates. However, dimeric 2'-5'-adenylates do not bind, and therefore, they cannot be detected. Thus, the test gives Information only about the amount of biologically active oligoadenylates, and an exact determination of the turnover rate of the 2'-5'-oligoadenylate synthetase reaction is not possible.
Furthermore, we investigated the possibility of üsing an ATP chemiluminescence assay for the determination of 2 / -5'-oligoadenylate synthetase (30) , in order to avoid handling radioactivity (data not shown). Although the determination of ATP (its decrease during the 2'-5'-oligoadenylate synthetase reaction) is more advantageous than the determination of the heterogeneous 2'-5'-oligoadenylates, a relatively high ATP turnover is necessary in order to get Signals clearly distinguishable from the ATP signal at the Start of the reaction. However, äs already mentioned, it is hardly possible to perform the 2'-5'-oligoadenylate synthetase reaction under Saturation conditions and therefore, the general applicability of the ATP chemiluminescence assay is restricted.
For clinical investigations, two types of Information can be obtained by the 2'-5'-oligoadenylate synthetase assay:
1) The basal levels of 2'-5'-oligoadenylate synthetase in peripheral mononuclear blood cells from patients, expressed relative to Standards (healthy person, set äs 1.0).
2) The elevation factor, expressed äs the ratio of 2'-5'-oligoadenylate synthetase levels before and after in vitro treatment of cells with interferon. The determination of this factor provided very useful additional information, e. g. compared with valües obtained from healthy persons, this factor was found to be reduced in peripheral mononuclear blood cells from patients with acquiired immunodeficiency syndrome (AIDS) (8) or from children with severe immunodeficiency syndrome (20) . The elevation factor is influenced by several parameters (type of interferon; type of foetal calf serum used for incubation; incubation time); additionally, it made a considerable difference to the results if the cell lysate of the peripheral blood mononuclear cells, which was not treated with interferon, was prepared immediately after Isolation from peripheral blood or after a simultaneous overnight incubation using an interferon-free medium. In all experiments described here, untreated peripheral blood mononuclear cells were used after overnight incubation.
In our own investigations described above, the basal levels of 2'-5 / -oligoadenylate synthetase in peripheral blood mononuclear cells from children with chronic myelogenous leukaemia were found to be strongly reduced, compared with healthy controls. This is in agreement with the Suggestion that 2'-5'-oligoadenylate snythetase (äs part of the antiproliferative 2'-5'-oligoadenylate System) is low in undifferentiated and proliferating cells. However, these low basal levels can be elevated drastically after in vitro treatment with interferon. Independently of its diagnostic significance, the biological importance of this elevation remains to be clarified, because the elevation of 2'-5'-oligoadenylate synthetase alone is not in itself sufficient to produce antiproliferative (or antiviral) effects; oligoadenylates can be formed and the 2'-5'-oligoadenylate System becomes operative, only in the presence of dsRNA. It can be speculated that mRNAs coding for proteins engaged in proliferative processes (e. g. from oncogenes or growth factors) could serve äs target molecules for the selective attachment and activation of the 2'-5'-oligoadenylate synthetase, provided that these mRNAs can form partial double stfanded chains (e.g. by chain refolding). Such a mechanism is possibly responsible for the selective degradation of the myc-oncogene mRNA, observed after interferon treatmefit of lymphoblastoid Daudi cells (31^34). Whether this principle may also play a role in chronic myelogenous leukaemia, or other malignant diseases influenced by interferon, is still an open question.
